Naoka Murakami

3.0k total citations
68 papers, 1.3k citations indexed

About

Naoka Murakami is a scholar working on Transplantation, Oncology and Surgery. According to data from OpenAlex, Naoka Murakami has authored 68 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Transplantation, 22 papers in Oncology and 16 papers in Surgery. Recurrent topics in Naoka Murakami's work include Renal Transplantation Outcomes and Treatments (25 papers), Polyomavirus and related diseases (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Naoka Murakami is often cited by papers focused on Renal Transplantation Outcomes and Treatments (25 papers), Polyomavirus and related diseases (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Naoka Murakami collaborates with scholars based in United States, Japan and Canada. Naoka Murakami's co-authors include Leonardo V. Riella, Takao Shimizu, Takehiko Yokomizo, Toshiaki Okuno, Thiago J. Borges, Tomohiro Funakoshi, Shveta S. Motwani, M Yamashita, Koichi Yuki and Ala Abudayyeh and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Naoka Murakami

67 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoka Murakami United States 19 445 315 290 263 251 68 1.3k
Sally Self United States 20 211 0.5× 207 0.7× 218 0.8× 286 1.1× 351 1.4× 55 1.2k
Álex Gutiérrez-Dalmau Spain 15 428 1.0× 151 0.5× 477 1.6× 124 0.5× 386 1.5× 34 1.2k
John R. Silkensen United States 12 471 1.1× 250 0.8× 302 1.0× 225 0.9× 185 0.7× 15 1.1k
Kenneth A. West Canada 19 210 0.5× 272 0.9× 573 2.0× 467 1.8× 250 1.0× 50 1.6k
Rossana Franzin Italy 20 178 0.4× 454 1.4× 98 0.3× 234 0.9× 194 0.8× 39 1.2k
Min Gu China 21 132 0.3× 891 2.8× 190 0.7× 175 0.7× 423 1.7× 111 1.6k
Y Takemoto Japan 21 259 0.6× 471 1.5× 87 0.3× 358 1.4× 148 0.6× 74 1.6k
Laurent Mesnard France 22 128 0.3× 435 1.4× 227 0.8× 369 1.4× 214 0.9× 92 1.8k
Oscar Imventarza Argentina 19 210 0.5× 240 0.8× 339 1.2× 116 0.4× 855 3.4× 81 1.5k
Alexander C. Wiseman United States 25 218 0.5× 149 0.5× 944 3.3× 247 0.9× 843 3.4× 72 1.7k

Countries citing papers authored by Naoka Murakami

Since Specialization
Citations

This map shows the geographic impact of Naoka Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoka Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoka Murakami more than expected).

Fields of papers citing papers by Naoka Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoka Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoka Murakami. The network helps show where Naoka Murakami may publish in the future.

Co-authorship network of co-authors of Naoka Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Naoka Murakami. A scholar is included among the top collaborators of Naoka Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoka Murakami. Naoka Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merzkani, Massini, et al.. (2025). Immunotherapy and cellular therapies for cancers in kidney transplant patients. American Journal of Nephrology. 1–23. 1 indexed citations
2.
Yazawa, Masahiko, Naoka Murakami, Akira Nishiyama, et al.. (2025). Water and electrolyte abnormalities in novel pharmacological agents for kidney disease and cancer. Clinical and Experimental Nephrology. 29(5). 521–533. 3 indexed citations
3.
Wang, Jian, Jacqueline H. Stephens, Annabelle Wilson, et al.. (2025). Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors. JAMA Oncology. 11(10). 1150–1150. 3 indexed citations
4.
Herrmann, Sandra M., Ala Abudayyeh, Shruti Gupta, et al.. (2024). Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrology. Kidney International. 107(1). 21–32. 12 indexed citations
5.
Kuwabara, Takashige, Teruhiko Mizumoto, Takeshi Matsubara, et al.. (2024). SUrvey of renal Biopsy registry database and Anticancer dRUg therapy in Japan (SUBARU-J study). Clinical Kidney Journal. 17(12). sfae327–sfae327. 3 indexed citations
6.
Hanna, Glenn J., Anita Giobbie‐Hurder, Vatche Tchekmedyian, et al.. (2024). Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. Journal of Clinical Oncology. 42(9). 1021–1030. 29 indexed citations
7.
Murakami, Naoka, Amanda J. Reich, Katherine He, et al.. (2023). Kidney Transplant Clinicians’ Perceptions of Palliative Care for Patients With Failing Allografts in the US: A Mixed Methods Study. American Journal of Kidney Diseases. 83(2). 173–182.e1. 2 indexed citations
8.
Esmail, Abdullah, Ala Abudayyeh, Naoka Murakami, et al.. (2023). Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology. Cancers. 15(5). 1433–1433. 12 indexed citations
9.
Dunlap, Garrett S., Daniel DiToro, Joel Henderson, et al.. (2023). Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy. Nature Communications. 14(1). 1549–1549. 13 indexed citations
10.
Murakami, Naoka, Thomas Hills, Hanny Al‐Samkari, et al.. (2022). Therapeutic advances in COVID-19. Nature Reviews Nephrology. 19(1). 38–52. 92 indexed citations
11.
Gassen, Rodrigo Benedetti, Thiago J. Borges, María José Pérez‐Sáez, et al.. (2022). T cell depletion increases humoral response by favoring T follicular helper cells expansion. American Journal of Transplantation. 22(7). 1766–1778. 15 indexed citations
12.
Murakami, Naoka, Margaret L. Schwarze, Keren Ladin, et al.. (2022). Top Ten Tips Palliative Care Clinicians Should Know About Solid Organ Transplantation. Journal of Palliative Medicine. 25(7). 1136–1142. 7 indexed citations
13.
Blosser, Christopher D., et al.. (2022). Transplant Onconephrology: An Update. Seminars in Nephrology. 42(6). 151348–151348. 1 indexed citations
14.
Cron, David C., Naoka Murakami, Lingwei Xiang, et al.. (2022). Anastomosis Time and Outcomes after Donation after Circulatory Death Kidney Transplantation. Journal of the American College of Surgeons. 234(6). 999–1008. 2 indexed citations
15.
Murakami, Naoka, Allison B. Webber, & Vinay Nair. (2022). Transplant Onconephrology in Patients With Kidney Transplants. Advances in Chronic Kidney Disease. 29(2). 188–200.e1. 5 indexed citations
16.
Wongboonsin, Janewit, et al.. (2021). Osmotic Tubulopathy in a Patient With COVID-19 Treated With Remdesivir. Kidney International Reports. 6(7). 1987–1991. 4 indexed citations
17.
Win, Thet Su, Beatrice Dyring‐Andersen, Jessica E. Teague, et al.. (2021). Immunoregulatory and lipid presentation pathways are upregulated in human face transplant rejection. Journal of Clinical Investigation. 131(8). 21 indexed citations
18.
Léon, Juliette, María José Pérez‐Sáez, Audrey Uffing, et al.. (2018). Effect of Combined Gluten-Free, Dairy-Free Diet in Children With Steroid-Resistant Nephrotic Syndrome: An Open Pilot Trial. Kidney International Reports. 3(4). 851–860. 7 indexed citations
19.
Bai, Lin, Pradeep K. Singh, Naoka Murakami, et al.. (2017). Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes. Nature Communications. 8(1). 1692–1692. 45 indexed citations
20.
Grafals, Mónica, Brian S. Smith, Naoka Murakami, et al.. (2014). Immunophenotyping and Efficacy of Low Dose ATG in Non-Sensitized Kidney Recipients Undergoing Early Steroid Withdrawal: A Randomized Pilot Study. PLoS ONE. 9(8). e104408–e104408. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally Self Breakdown of academic impact, for papers by Álex Gutiérrez-Dalmau Breakdown of academic impact, for papers by John R. Silkensen Breakdown of academic impact, for papers by Kenneth A. West Breakdown of academic impact, for papers by Rossana Franzin Breakdown of academic impact, for papers by Min Gu Breakdown of academic impact, for papers by Y Takemoto Breakdown of academic impact, for papers by Laurent Mesnard Breakdown of academic impact, for papers by Oscar Imventarza Breakdown of academic impact, for papers by Alexander C. Wiseman
Rankless by CCL
2026